(Total Views: 430)
Posted On: 07/20/2021 12:04:07 PM
Post# of 9144
This just arrived in my mailbox:
Second Rapid Viral Assay (RVA) Patent Granted
Technology can be configured to detect viruses including COVID19 and Variants, HIV, HPV, SARS, MERS, and others without limitation
We are pleased to announce the issuance of United States patent 1106612, "Rapid Viral Assay", for detection and diagnosis of COVID19 (SARS-2) and other viruses.
United States Patent: 11066712 (uspto.gov)
This is a Continuation-In-Part for the RVA Family of Technology initially granted with US Patent 10844442 on November 24, 2020
A further Continuation-In-Part application for an additional patent related to detection of spontanaeous viral mutations and other claims was filed with the USPTO yesterday.
Full details of the granted patent, with the complete list of granted claims, is available in the USPTO Patent Gazette Week 29 publication.
This information can be accessed by entering the patent number of 1106612 after following this link:
http://patentsgazette.uspto.gov/week29/
Second Rapid Viral Assay (RVA) Patent Granted
Technology can be configured to detect viruses including COVID19 and Variants, HIV, HPV, SARS, MERS, and others without limitation
We are pleased to announce the issuance of United States patent 1106612, "Rapid Viral Assay", for detection and diagnosis of COVID19 (SARS-2) and other viruses.
United States Patent: 11066712 (uspto.gov)
This is a Continuation-In-Part for the RVA Family of Technology initially granted with US Patent 10844442 on November 24, 2020
A further Continuation-In-Part application for an additional patent related to detection of spontanaeous viral mutations and other claims was filed with the USPTO yesterday.
Full details of the granted patent, with the complete list of granted claims, is available in the USPTO Patent Gazette Week 29 publication.
This information can be accessed by entering the patent number of 1106612 after following this link:
http://patentsgazette.uspto.gov/week29/
(2)
(0)
